HALSTON COLEMAN: Open Payments
NPI 1942531819 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,001 in 42 payments from 13 companies in 2025. Trend: 2023 $357 · 2024 $367 · 2025 $1,001
Food & beverage: $1,001
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $439 |
| Aveo Pharmaceuticals, Inc. | 4 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $91 |
| PFIZER INC. | 3 | $72 |
| Merck Sharp & Dohme LLC | 3 | $65 |
| Ferring Pharmaceuticals Inc. | 2 | $46 |
| Dendreon Pharmaceuticals LLC | 2 | $38 |
| Astellas Pharma US Inc | 2 | $32 |
| IMMUNITYBIO, INC. | 1 | $30 |
| Davol Inc. | 1 | $28 |
Products named: ERLEADA, RYBREVANT, XTANDI, FOTIVDA, Nubeqa, KEYTRUDA, ADSTILADRIN, PROVENGE.
Industry payments across OK — which companies pay providers there.
